|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-4.58/-1.50
|
企業價值
15.69M
|
資產負債 |
每股賬面淨值
8.03
|
現金流量 |
現金流量率
--
|
損益表 |
收益
2.04M
|
每股收益
0.17
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/05/21 12:56 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. |